title: Vibrating-mesh nebulization of liposomes generated using an ethanol-based proliposome technology.
abstract: This is the first study that evaluates the influence of the compartmental design of the micropump Aeroneb Go nebulizer and the viscosity of a proliposome hydration medium on vibrating-mesh aerosolization of liposomes. Ethanol-based proliposomes comprising soya phosphatidylcholine and cholesterol (1:1 mole ratio) were hydrated by using isotonic NaCl (0.9%) or sucrose (9.25%) solutions to generate liposomes that entrapped approximately 61% of the hydrophilic drug, salbutamol sulphate. Liposomes were aerosolized by the nebulizer to a two-stage impinger. For both formulations, the aerosol mass output was higher than the phospholipid output, indicating some accumulation of large liposomes or liposome aggregate within the nebulizer. Using NaCl (0.9%) solution as the dispersion medium, aerosol droplet size was much smaller and aerosol mass and phospholipid outputs were higher. This was attributed to the lower viscosity of the NaCl solution, resulting in a reduced retention of the aerosols in the "trap" of the nebulizer. For the entrapped salbutamol sulphate, although the "fine particle fraction" was relatively high (57.44%), size reduction of the liposomes during nebulization caused marked losses of the drug originally entrapped. Overall, liposomes generated from proliposomes when using this nebulizer showed high nebulization output and small droplet size. However, further work is required to reduce the losses of the originally entrapped drug from liposomes.
authors.affiliation: School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, United Kingdom. AElhissi@uclan.ac.uk
authors.forename: Abdelbary
authors.initials: A
authors.lastname: Elhissi
authors.forename: Hardyal
authors.initials: H
authors.lastname: Gill
authors.forename: Waqar
authors.initials: W
authors.lastname: Ahmed
authors.forename: Kevin
authors.initials: K
authors.lastname: Taylor
mesh_terms: D000280:Administration, Inhalation; D000336:Aerosols / Q000737:chemistry / Q000378:metabolism*; D000420:Albuterol / Q000737:chemistry / Q000378:metabolism*; D001993:Bronchodilator Agents / Q000737:chemistry / Q000378:metabolism*; D002784:Cholesterol / Q000737:chemistry; D004355:Drug Stability; D000431:Ethanol / Q000737:chemistry; D008081:Liposomes / Q000737:chemistry* / Q000378:metabolism; D046529:Microscopy, Electron, Transmission; D036103:Nanotechnology / Q000379:methods*; D009330:Nebulizers and Vaporizers; D010316:Particle Size; D010713:Phosphatidylcholines / Q000737:chemistry; D012965:Sodium Chloride / Q000494:pharmacology; D013025:Glycine max / Q000737:chemistry; D013395:Sucrose / Q000494:pharmacology; D014732:Vibration; D014783:Viscosity / Q000187:drug effects
chemical_list: D000336:Aerosols; D001993:Bronchodilator Agents; D008081:Liposomes; D010713:Phosphatidylcholines; D000431:Ethanol; D012965:Sodium Chloride; D013395:Sucrose; D002784:Cholesterol; D000420:Albuterol